JULY 20216JULY - 26 - 2021, volume 05 - Issue 07 (ISSN 2691-4093) Published by ValleyMedia, Inc. Managing EditorAlex D'souzaEditorial StaffVisualizerChris LynnSalesAndrew D'Souzaandrew.dsouza@medicaltechoutlook.comEmailsales@medicaltechoutlook.comeditor@medicaltechoutlook.commarketing@medicaltechoutlook.comJoshua Parker Merlin WatsonJoe Philip Laura PintoTo subscribe to MedicalTech OutlookVisit www.medicaltechoutlook.com Copyright © 2021 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffAlex D'souzaManaging Editoreditor@medicaltechoutlook.comAs the prevalence of neurodegenerative and neurological disorders are increasing alarmingly, so is our know-how on these disorders. For instance, while the feasibility of mapping distinguishable regions of the human brain in relation to their functional roles seemed remote earlier, today, the tremendous advancements made in neurosciences enable us to discern the mechanisms that underlie sensory perceptions and locomotor functions. Consequently, the increasing insights into the genetics and molecular bases of neurodegenerative and neurological disorders are opening new scopes for specific and personalized treatments. Notably, the efficacy and reliability of novel neurology devices will play a vital role in translating these technological advancements into clinical benefits. On that front, neurointerventional and neurostimulation devices will gain more prominence among neurologists due to advanced surgical technology and the advantageous feature of minimal invasiveness. The demand for non-invasive hybrid brain-computer interface (HBCI) technologies will also surge to improve the accuracy of neurodiagnostic procedures. In this edition of MedTech Outlook, we present to you Progressive NEURO, an emerging neurology device provider that develops a unique portfolio of progressive stroke solutions to put forth treatment options beyond conventional aspiration and thrombectomy. This edition further brings you the story of some of the most promising emerging neurology device providers that deliver the best outcomes for their clients. This edition also offers a combination of thought leadership articles from subject matter experts and exclusive insights from CXOs. We hope this edition will provide you with the right assistance in choosing the best emerging neurology device provider according to your requirements.Let us know your thoughts!Stepping into an Era of Significant InnovationsSarah FernandesEDITORIAL
< Page 5 | Page 7 >